CENTRAL LABORATORIES FEATURED ARTICLES
CENTRAL LABORATORIES WHITE PAPERS & ARTICLES
-
![Risk Management-GettyImages-584210406]( "From Standards To Study Conduct: The Operational Reality Of RBQM")
From Standards To Study Conduct: The Operational Reality Of RBQMOperationalizing risk-based quality management requires early identification of critical-to-quality factors, cross-functional collaboration, integrated systems, and a cultural shift toward proactive, proportionate trial oversight.
-
![modern medical healthcare, telemedicine-GettyImages-2228735046]( "How Regulatory Convergence Is Rewriting Clinical Data Management")
How Regulatory Convergence Is Rewriting Clinical Data ManagementRegulatory shifts toward structured, digital clinical trial protocols are reducing manual interpretation, enabling risk-based oversight, and supporting more efficient, transparent, end-to-end trial execution.
-
![genetic research, biotechnology, molecular biology, innovation, healthcare solutions-GettyImages-2234236209]( "Develop A Comprehensive Strategy For Implementing AI & Multi-Omics")
Develop A Comprehensive Strategy For Implementing AI & Multi-OmicsDiscover how a strategy-first approach to AI and multi-omics transforms complex biological data into actionable clinical decisions and more precise, targeted oncology therapies for 2026 and beyond.
-
![GettyImages-2172328990-5-five]( "5 Projections For 2026: Navigating The New Normal In Clinical Trials")
5 Projections For 2026: Navigating The New Normal In Clinical TrialsIn 2026, clinical trial success depends on moving from AI hype to proven utility. Unified data and seamless site experiences are no longer optional; they are the keys to trial resilience.
-
![clinical-trial-tech-ai-GettyImages-2226144959]( "Shaping The Future Of Clinical Trial Technology With tPlatform Unification")
Shaping The Future Of Clinical Trial Technology With tPlatform UnificationAs we look toward 2026, the conversation around clinical trial technology is shifting from simple digitization to true platform unification.
CENTRAL LABORATORIES APPLICATIONS & STUDIES
-
Changing The Clinical Feasibility Game With AI1/22/2026
AI is only as good as the data it’s built upon. Our customized AI platforms are constructed on a foundation of trustworthy, carefully curated data to produce detailed, expert-driven responses.
-
Drilling Down On Diversity And Feasibility12/8/2025
A mid-sized contract research organization (CRO) sought help with writing clinical trial diversity action plans and assessing feasibility for therapeutic areas outside its usual scope.
-
Accelerating Clinical Data Review With Traceable Workflows12/3/2025
Clinical data review needs centralized access and traceable workflows. Leveraging AI-automation and real-time collaboration drives faster, better-informed decisions and reduced compliance risk.
-
Rescuing Data Integrity: A Swift Transition And Quality Transformation11/14/2025
Uncover how this collaboration supported timely progress toward key study milestones, enabling smoother execution and more dependable output across data management and statistical activities.
-
Effect Of Etrasimod On Immune Cell Subsets In Colonic Tissue9/25/2025
Etrasimod selectively modulates S1P receptors to reduce inflammation and immune cell trafficking to the gut, showing promise in treating moderate to severe ulcerative colitis.
CENTRAL LABORATORIES PRODUCTS & SERVICES
Enable secure, flexible data exchange with open REST integrations—streamlining workflows, reducing manual effort, and supporting modern, audit‑ready clinical operations.
Avance Clinical has located its Asia hub operations in Seoul, South Korea which is highly regarded for its advanced technology and scientific and medical excellence.
Biostatistical services, including SAP development, statistical programming in SAS, analysis, submission-ready services and statistical reports are customized and designed specifically to meet your project requirements.
Ideagen Quality Management is a modular SaaS solution designed with the needs of quality managers in mind. Trusted by more than 6,000 customers worldwide to digitalize their quality management processes and comply with industry standards.
Today’s clinical researchers need precise, timely, and reliable solutions for managing huge amounts of diverse data. TrialKit AI is here to meet this demand.
Trial@home, CHDR’s dedicated strategy for off-site clinical trials, enables investigators to collect information as trial participants go about their day to day activities.
Neither traditional nor hybrid clinical trials can operate on rigid EDC systems.
They require flexible data collection systems that support protocol amendments without downtime and accept mobile data without hassle. As a cloud-native solution, TrialKit bends to accommodate mid-study changes. And as the first full-featured EDC platform available as a native mobile app, TrialKit flexes to meet the demands of traditional, hybrid/decentralized, and completely remote clinical trials.
Give your team the freedom to build, deploy, and manage their studies, their way—weeks faster than with rigid EDCs and for a fraction of the cost of the major players.
CENTRAL LABORATORIES SOLUTIONS
- Leading The Way In Patient Payments
- Reliable Endpoints Powering Successful Signal Detection
- How The Sitetrove Diversity Module Can Diversify Studies
- Integrate Your Data To Get The Full Picture
- Data-Powered Financial Management For Your Clinical Trials
- Technology Solutions And Services Tailored For Emerging Biopharma
- Medidata Decentralized Clinical Trials (DCT) Program
- Standardized Data In One Place
- Signant SmartSignals® Advisory
- Site Cloud: End Of Study (EOS)
VIDEOS
- Keeping Your Trials In Motion And Use AI Where It Makes Sense
- Streamline Data Entry With EHR-To-EDC Software
- Revolutionize Data Access With An AI Powered Custom Listing Generator
- How AI-Enhanced CAPA Systems Cut Non-Conformances By Targeting Root Causes
- The Industry’s First And Only Unified Platform For RWE Generation
NEWS
- Sygnature Discovery Unveils Strategic Rebrand To Cement Status As A Global Drug Discovery Partner
- Suvoda Sets New Standard For Streamlined Patient And Site Experience In Clinical Trials
- Suvoda IRT Named A Leader In Everest Group's RTSM PEAK Matrix®
- Altasciences Announces Chris Perkin Appointed To Board Of Directors; Marie-Hélène Raigneau Appointed Chief Executive Officer
- AI Agent Enhances Principal Investigator Oversight Of eCOA Data
- Medable Debuts AI Agent for Automating Trial Master File (TMF) Processes
- Univo IRB And The Patient View Announce Partnership
- Avance Clinical Launches Diversity In STEM Scholarships Across Australia And North America
- Lindus Health And Quotient Sciences Partner To Accelerate Drug Development From First-In-Human To Pivotal Trials
- Integrating Lyft Healthcare As An Affordable On-Demand Transportation Provider For Clinical Trial Participants: A Move Towards Enhanced Patient Experience
- Yoncare s.r.o. Partners With Block Clinical Inc. To Deliver EU-Centric Clinical Trial Participant Travel And Payment Services In Europe
- Block Clinical Discusses Patient Travel Support With Panel Members
- Quotient Sciences And Intrepid Labs Form Strategic Partnership To Accelerate AI-Guided Formulation Development
- One App To Simplify The Clinical Trial Journey
- Avance Clinical Showcases Early Phase Expertise And The Australian Advantage For EU Biotechs At BIO-Europe Vienna
- Meet Avance Clinical At SCOPE Summit 2026 In Orlando, Florida
- Signant Health Appoints Internationally Recognized Cognitive Assessment Expert John Harrison To Further Advance Innovation In CNS Clinical Trials
- Avance Clinical Launches Renal And Cardiometabolic Center Of Excellence To Optimize Patient Recruitment To Elevate Study Success
- Avance Clinical Unveils Dedicated CNS Center Of Excellence For Expert Clinical Trial Services In Neuroscience
- Suvoda Expands EU Patient Travel with Bolt Partnership
- Avance Clinical Launches Dedicated Center Of Excellence To Accelerate Early Phase Biotech Trials
- Castor Catalyst: Launching Self-Driving Clinical Trials With Google Cloud AI
- Almac Trial Coordinator Launched In $48 Million Investment To Advance Integrated eClinical Technologies
- Quotient Sciences And Biorasi Partner To Accelerate Early Phase Clinical Trials To Patient Proof-Of-Concept
- Biorasi Unveils New Website To Drive Sponsor Success With Biotech-Centric Strategies And Modular CRO Solutions
- Suvoda And Greenphire Complete Brand Integration With Unified Website And Social Media Presence
- Avance Clinical Accelerates Time To Pivotal Milestones For More Than 700 Emerging Biotechs
- Avance Clinical Attends Reception Welcoming Australia's US Ambassador To North Carolina Governor's Executive Mansion In Raleigh, N.C.
- Avance Clinical Strengthens Korea Focus: Seoul Meeting Highlights Growth, Partnerships, And Regional Collaboration
- "Most-Favored Nation" Drug Pricing Strategy May Backfire, New Research Warns